Vanadium inhibits Type 2 diabetes mellitus-induced aortic ultrastructural alterations associated with the Inhibition of dyslipidemia and biomarkers of inflammation in rats
Int. j. morphol; 38 (1), 2020
The potential inhibitory effect of the insulin mimicking agent, vanadium on type 2 diabetes mellitus (T2DM)induced alterations to the aorta ultrastructure associated with the suppression of dyslipedima and biomarkers of inflammation has not been investigated before. Therefore, we tested whether vanadium ...
Vanadio/administración & dosificación, Aorta/ultraestructura, Aorta/efectos de los fármacos, Diabetes Mellitus Tipo 2/complicaciones, Enfermedades de la Aorta/etiología, Dislipidemias/tratamiento farmacológico, Vanadio/farmacología, Inflamación/tratamiento farmacológico, Modelos Animales de Enfermedad, Microscopía Electrónica de Transmisión, Aorta/lesiones, Ratas Sprague-Dawley